Rozporządzenie Ministra Zdrowia z dnia 24 lutego 2023 r. zmieniające rozporządzenie w sprawie programu pilotażowego leczenia gruźlicy wielolekoopornej w warunkach ambulatoryjnych | Dz.U. 2023 poz. 372 — Poland law | Esheria

Rozporządzenie Ministra Zdrowia z dnia 24 lutego 2023 r. zmieniające rozporządzenie w sprawie programu pilotażowego leczenia gruźlicy wielolekoopornej w warunkach ambulatoryjnych

This preamble identifies the regulation as an amending regulation about a pilot program for outpatient treatment of multidrug-resistant tuberculosis and states that the Minister of Health administers the health government department.

AI-assisted research synopsis — verify against the official legal text below.

Jurisdiction
Poland
Instrument
Regulation
Citation
Dz.U. 2023 poz. 372
Version
Undated source snapshot
Language
pl
Updated
Official source
View official record ↗
leczenie gruźlicy MDR-TB regulatory amendment świadczenia opieki zdrowotnej

Publicly available, excluded from search-engine indexing

This page remains available for direct access and API use, but this release emits noindex,follow for the following reason:

  • The record does not meet this release's canonical indexing criteria. (market-indexing-disabled)

Statute overview

About this statute

This preamble identifies the regulation as an amending regulation about a pilot program for outpatient treatment of multidrug-resistant tuberculosis and states that the Minister of Health administers the health government department. The provided excerpt contains only numbering markers and no readable substantive rule. This provision amends an existing health regulation, changing one visit frequency from monthly to once every three months and adding a final medical consultation fee of 150 zł for MDR-TB treatment. It also updates the annex list of facilities and states the regulation takes effect the day after publication.